Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists

OBJECTIVE: To survey practising hepatologists about their attitudes and practices regarding interferon and ribavirin combination therapy for hepatitis C (HCV) patients in Canada.

Saved in:
Bibliographic Details
Main Authors: Peter Wang, Qilong Yi, Linda Scully, Jenny Heathcote, Murray Krahn
Format: Article
Language:English
Published: Wiley 2003-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2003/498120
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691446165110784
author Peter Wang
Qilong Yi
Linda Scully
Jenny Heathcote
Murray Krahn
author_facet Peter Wang
Qilong Yi
Linda Scully
Jenny Heathcote
Murray Krahn
author_sort Peter Wang
collection DOAJ
description OBJECTIVE: To survey practising hepatologists about their attitudes and practices regarding interferon and ribavirin combination therapy for hepatitis C (HCV) patients in Canada.
format Article
id doaj-art-e8998f1ae4964e2dbaa2665b88e0656a
institution DOAJ
issn 0835-7900
language English
publishDate 2003-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-e8998f1ae4964e2dbaa2665b88e0656a2025-08-20T03:21:02ZengWileyCanadian Journal of Gastroenterology0835-79002003-01-0117318318610.1155/2003/498120Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian HepatologistsPeter Wang0Qilong Yi1Linda Scully2Jenny Heathcote3Murray Krahn4The Toronto General Hospital, University Health Network, Toronto, Ontario, CanadaOntario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Ontario, CanadaToronto Western Hospital, University Health Network, Toronto, Ontario, CanadaDivision of Gastroenterology, The Ottawa Hospital, Ottawa, Ontario, CanadaThe Toronto General Hospital, University Health Network, Toronto, Ontario, CanadaOBJECTIVE: To survey practising hepatologists about their attitudes and practices regarding interferon and ribavirin combination therapy for hepatitis C (HCV) patients in Canada.http://dx.doi.org/10.1155/2003/498120
spellingShingle Peter Wang
Qilong Yi
Linda Scully
Jenny Heathcote
Murray Krahn
Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
Canadian Journal of Gastroenterology
title Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
title_full Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
title_fullStr Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
title_full_unstemmed Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
title_short Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
title_sort indications for interferon ribavirin therapy in hepatitis c patients findings from a survey of canadian hepatologists
url http://dx.doi.org/10.1155/2003/498120
work_keys_str_mv AT peterwang indicationsforinterferonribavirintherapyinhepatitiscpatientsfindingsfromasurveyofcanadianhepatologists
AT qilongyi indicationsforinterferonribavirintherapyinhepatitiscpatientsfindingsfromasurveyofcanadianhepatologists
AT lindascully indicationsforinterferonribavirintherapyinhepatitiscpatientsfindingsfromasurveyofcanadianhepatologists
AT jennyheathcote indicationsforinterferonribavirintherapyinhepatitiscpatientsfindingsfromasurveyofcanadianhepatologists
AT murraykrahn indicationsforinterferonribavirintherapyinhepatitiscpatientsfindingsfromasurveyofcanadianhepatologists